ABSTRACT Comparative tryptic peptide analysis was used to probe the structure of the TL products coded for by normally expressed TL alleles (Tlaa and TlaC haplotypes) and the structure of the TL product on ERLD, a TL+ leukemia occurring in a strain that does not normally express TL antigens (Tiab haplotype). In mice that have the Tid' haplotype, the peptide maps of TL glycoproteins from normal thymocytes and from TL+ leukemias were identical, a finding that is consistent with the indistinguishable serologically defined TL phenotype of these cells. Analysis of the Th product on ERLD leukemia cells (TL phenotype, TL.1,2,4) indicates a single TL glycoprotein species with the TL.4 determinant (restricted to leukemias of Tiab and Tiac haplotypes) coexisting on the same glycoprotein as the TL. 1 determinant (normally expressed by thymocytes of Tiaa haplotype). Comparison of the peptides of the TL product of ERLD and the products of the normally expressed Tid' and TLaC loci showed a high degree of structural similarity (i.e., 70-80%) ofshared peptides. In contrast, the products of the Tlaa, Tlab, and TlaC loci shared relatively few peptides with the products of the K, D, and L loci of the closely linked major histocompatibility complex (15-35%). The TL family, therefore, consists of alleles that are highly homologous. This contrasts with the marked diversity and polymorphism among the alleles of the K, D, and L loci.
systems (2) . In certain strains of mice (designated TL+ strains), TL has the characteristics of a differentiation antigen, expression being limited to thymocytes and leukemia cells of thymic origin. In other strains (TL-strains), TL is not normally expressed on thymocytes, but can be detected on leukemia cells. The usual explanation given for these findings is that all strains of mice have the genetic information for TL but strains differ with regard to regulatory sequences controlling expression vs. nonexpression of TL on normal thymocytes. Leukemogenesis disrupts this regulatory control of TL in TL-strains, resulting in the expression ofnormally silent TL genes and the anomalous appearance of TL antigens on leukemia cells.
Mendelian analysis ofTL expression in normal mice showed that the controlling locus (designated Tla) is closely linked to the H-2 complex on chromosome 17, 1 to 2 centimorgans to the right ofthe H-2D locus, and there are several reasons to believe that this is also the site ofthe TL structural gene (3) . In addition to close genetic linkage between Tla and H-2, the products of these two loci show certain biochemical similarities (4, 5) , and antibody blocking studies indicate a close spatial apposition of these two components on the cell surface (6) . Both the major histocompatibility complex (MHC) H-2 and the TL antigens consist of similar molecular complexes, containing a Mr 45,000 glycoprotein and a noncovalently associated Mr 12 ,000 protein (4, 5, (7) (8) (9) . Despite these similarities, H-2 and TL differ in a number ofways. H-2 antigens are expressed on virtually all cells ofthe body, whereas TL antigens are normally restricted to thymocytes in TL+ strains. In contrast to the remarkable polymorphism of H-2 (10) , only six TL specificities have been defined to date, one of them, TL. 4 , never having been detected on normal cells (2, 11 (12) (13) (14) (15) .
Past structural.studies have focused on TL antigens on thymocytes and leukemia cells ofTL+ strains. To gain information about both normally and abnormally expressed TL antigens, the technique of tryptic peptide analysis has been used to probe (i) the structure of the TL products coded for by normally expressed TL alleles (Tlaa and TlaC); (ii) the structure of the TL product exbpressed by ERLD, a TL+ leukemia arising in a TL strain (Tla ); and (iii) the relationship between the products of the TVaG, Tlab, and TVaC loci and the K, D, and L MHC products.
MATERIALS AND METHODS
Mice. C57BL/6 (B6) (H-2b, Tlab), B6-Tlaa (H-2b, Tlae), A (H-2', Tla5) and BALB/c (H-2d, Tlac) came from our colonies.
Leukemia Cells (2) . A strain origin: spontaneous leukemias ASLi and ASL6 and x-ray-induced leukemia RADA1; phenotype TL. 1,2,3. B6 origin: x-ray-induced leukemia ERLD; phenotype TL. 1,2,4. EL4 is a TL leukemia of C57BL origin. Antisera. TL antisera (2) (17, 18) . After treatment with NMS and GAMIG, the Nonidet P-40 extract containing 1 mM phenylmethanesulfonyl fluoride (Sigma) was partially purified by using a Lens culinaris hemagglutinin Sepharose 4B affinity column (19) . The fraction that eluted with 0.1 M a-methyl-D-mannoside (glycoprotein pool) was cleared of MuLV-related proteins by affinity chromatography with a mixture of goat anti-MuLV envelope glycoprotein and rabbit anti-MuLV sera (20, 21) . The unbound fraction was pooled and recycled twice. TL and H-2 antigens were recovered from this partially purified glycoprotein pool by indirect immunoprecipitation with aTL or aH-2 K, D, L and GAMIG or Staphylococcus aureus Cowan I (22) . The preparation of H-2Ld antigen used the aDd immunoadsorbant method (23) , except that 50 mM diethylamine, pH 10.5/ 0.25% Nonidet P-40 was used for elution.
Reduction and Allylation, Bio-Gel A Chromatography, Trypsin Digestion, and Ion Exchange Chromatography. These procedures were carried out as described (17) , except that the elution buffer for the Bio-Gel A column contained 0.02 M dithiothreitol (A grade, Calbiochem) and the trypsin digestion buffer included 0.1 M ammonium bicarbonate, pH 8.55.
Discontinuous NaDodSO4/Polyacrylamide Gel Electrophoresis. Samples were fractionated by electrophoresis using the discontinuous buffer system (24) .
RESULTS
General Biochemical Properties of TL Antigens. By using procedures similar to those reported (17, 18) , TL antigens were prepared from the lentil lectin-positive glycoprotein fraction of Nonidet P-40.lysates of TL+ thymocytes or leukemia cells. TL antisera, as well as NMS, precipitated several protein peaks from the glycoprotein pool, including a number ofhigh molecular weight components presumably unrelated to TL. To remove these unrelated components, the glycoprotein pool was fractionated on an affinity column of Sepharose coupled to heterologous anti-MuLV sera. Conventional TL antisera (aTL. 1 (Fig. 1A) . In addition, a Mr 12,000 peak was present (Fig. 1B) . Monoclonal aTL.3 precipitated a smaller amount of the high molecular weight contaminants. However, even with monoclonal antibody, clearing of extracts was an essential step to eliminate these unrelated materials from the immunoprecipitates.
Comparative NaDodSO4/polyacrylamide gel electrophoresis analysis of the TL heavy chain and the MHC H-2K or D heavy chains showed that TL has a lower mobility than H-2, corresponding to a Mr of-46,000 for TL and 45,000 for H-2Kk and H-2Dd ( Fig. 1C and D) . The smaller protein associated with the TL heavy chain in immunoprecipitates (Fig. 1B) purified by elution of Tlaa and H-2 heavy chain peak fractions from electrophoresis gels and combined samples were rerun on the same gels. H and L, human gamma globulin heavy chain and light chain, respectively; Cyt-C, cytochrome c; P-2m, 82-microglobulin. acid sequence analysis have shown that this Mr 12,000 component is identical to the ,&2 microglobulin found in association with H-2 antigens (unpublished results). All reactivity with aTL.1,2,3 was removed by clearing with aTL.3, suggesting that the three TL determinants are carried by a single molecular species (9) .
The overall recovery of arginine and lysine radioactivity in the glycoprotein fiaction ofNonidet P-40 extracts ofTL+ or TLleukemia cells was 2-5%. The comparable figure for recovery of glycoproteins from extracts of normal thymocytes was =1%. After immunoprecipitation and gel electrophoresis, the recovery of TL from normal or leukemia cells was one order of magnitude lower than that for H-2 antigens (0.1-0.5% vs. 2-5%).
Comparison of TL Products from Normal Tlaa and Tlac Mice. Normal thymocytes of B6-Tlaa mice (Tlaa) express TL. 1,2,3 determinants, whereas thymocytes of BALB/c mice (TlaC) express only the TL.2 determinant. Tryptic peptide analysis of TL glycoproteins from thymocytes of these two strains shows that the Tlaa and Tlac products are similar (Fig. 2) . Nearly 70% of the arginine and lysine peptides were found to be [NHlarginine-labeled Tlac from BALB/c thymocytes (-) Comparison of the Tlab* Product and the Products of the TiV' and TVac Alleles. Fig. 6 shows a comparative tryptic peptide analysis ofthe Tlaa and Tlab* products. Approximately 80% of the peptides were identical, when both lysine as well as arginine peptides were compared. A similar comparison of Tlab* and the Tlac products showed that these molecules share 70% of their arginine peptides. Table 1 summarizes the results of comparative peptide analysis of Tlaa, Tlab*, and Tlac products. The findings indicate that the products of these three TidV alleles show a high degree of structural similarity.
Comparison of TIla and H-2K, D, and L Products. Comparative tryptic peptide analysis was carried out on (i) the Tla product and the H-2Kk, Dd, and La products of RADA1 leukemia cells and (ii) the Tlab* product and the H-2Kb and Db products of ERLD leukemia cells (Fig. 7) . The results are summarized in Table 2 . It is clear that the Tla and the H-2 products share considerably fewer peptides than are shared by the members of the TL family. Thus, the Tlaa product shares 13-24% arginine peptides and 28-31% lysine peptides with Kk, Dd, or L . The comparison ofTlab* with Kb and Db products indicates a somewhat higher degree of sharing: 27-31% arginine and 28-34% lysine peptides. Tlab* and Db products showed the highest degree of sharing: 31% of arginine and 34% lysine peptides.
DISCUSSION
Comparison of the TL products of the three Tla haplotypes (Thaa, Tiab, and Tiac) analyzed by tryptic peptide mapping showed a high degree of structural homology. As summarized in Table 1 , the products of the three alleles shared 70-80% of their peptides. This degree of sharing is comparable with that found with MHC mutant products of the Kb haplotype, which share 85-95% of the peptides and for which only one or two amino acid differences have been noted between mutant and parental products (25) . This is in sharp contrast to the limited degree of peptide homology shown by allelic yroducts of the MHC K and D regions. For example, Kb and K products share only 35-40% of the arginine-and lysine-labeled peptides (17). At the primary sequence level, this degree ofpeptide homology means that 80% of the amino acid sequences are identical (26 
